Emerging Treatments in Ovarian Cancer and Advice for Community Oncologists
Dr Chirag A. Shah highlights novel emerging treatments in ovarian cancer and provides advice for community oncologists.
Niraparib for Ovarian Cancer
Chirag A. Shah, MD, details his personal clinical experience with using niraparib for ovarian cancer maintenance therapies.
PARP Inhibitor Maintenance Therapy for Ovarian Cancer
An expert shares data from several clinical trials on the use of PARP inhibitors for maintenance therapies in ovarian cancer.
Ovarian Cancer: Systemic Front-Line Treatments
Dr Chirag A. Shah explains the front-line treatment options for ovarian cancer and the factors considered in choosing maintenance therapies.
The Role of Molecular Testing in Ovarian Cancer
A gynecologic oncologist discusses the importance of molecular testing in ovarian cancer and how it influences treatment selection.
Case Presentation: A 59-Year-Old Woman with Ovarian Cancer
Chirag A. Shah, MD, presents and reviews the case of a 59-year-old woman with ovarian cancer.
2 Commerce Drive Cranbury, NJ 08512